Removing Clinical Trial Travel Logistics In The Height Of The COVID-19 Pandemic

By Michael Woodard, Senior Manager, Operations & Support

Overcoming Logistical Barriers

88% of sponsors and CROs worldwide say that removing financial and logistical barriers that could deter patients from participating in clinical trials is more important now than it was before the COVID-19 pandemic.

As you well know, clinical trials have been significantly impacted by COVID-19. Though they did not all come to an end, getting patients to their clinical trial appointments became much more complicated, especially after cross-border travel restrictions were enacted. These travel restrictions posed a particularly great challenge in Europe with numerous countries in proximity.

With these logistical challenges came the need for ingenuity – partnering with a travel provider who can navigate these difficult and uncertain times to ensure sustainability for the trial. This may be best described in the following short story.